Portfolio company
Turn Biotechnologies
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops mRNA medicines and delivery platforms for cellular rejuvenation and tissue repair to treat age-related conditions for patients and pharmaceutical partners.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
TURN BIO
This biotechnology company develops mRNA-based medicines to rejuvenate cells and treat age-related conditions for patients with dermatological, immunological, and osteoarthritic diseases.
Rejuvenation Technologies
This company develops mRNA-based telomere extension therapies to treat patients with pulmonary fibrosis, liver disease, and other age-related conditions.
Altos Labs
This biotechnology company develops cellular rejuvenation therapies to restore cell health and reverse diseases for patients with chronic illnesses and age-related disabilities.
Shift Bioscience
This biotechnology company develops cellular rejuvenation therapeutics and an AI-driven discovery platform for pharmaceutical researchers to treat age-related diseases.
Rejuveron
This biotechnology firm develops medicines and regenerative therapies targeting age-related diseases to improve healthspan for the aging population.
Medici Therapeutics
The company develops personalised mRNA cancer vaccines and T cell therapies for patients to treat tumours and combat age-related cellular decline.
clock.bio
This biotechnology company develops regenerative therapies for patients with age-related diseases by using gene-editing technology to decode cellular rejuvenation programs in human stem cells.
Rejuveron Life Sciences AG
This biotechnology company develops regenerative therapies and medicines for patients with age-related diseases and vision loss.
